Page 152 - Read Online
P. 152
Zhao et al. Developments in auxiliary examination of CJD
65. Young GS, Geschwind MD, Fischbein NJ, Martindale JL, Henry RG, Criteria for Creutzfeldt-Jakob Disease (CJD), 2010. Available
Liu S, Lu Y, Wong S, Liu H, Miller BL, Dillon WP. Diffusion-weighted from: http://www.cdc.gov/prions/cjd/diagnostic-criteria.html. [Last
and fluid-attenuated inversion recovery imaging in Creutzfeldt-Jakob accessed on June 21, 2017]
disease: high sensitivity and specificity for diagnosis. AJNR Am J 68. Nagoshi K, Sadakane A, Nakamura Y, Yamada, Mizusawa H. Duration
Neuroradiol 2005;26:1551-62.
66. Meissner B, Körtner K, Bartl M, Jastrow U, Mollenhauer B, Schröter of prion disease is longer in Japan than in other countries. J Epidemiol
A, Finkenstaedt M, Windl O, Poser S, Kretzschmar HA, Zerr I. 2011;21:255-62.
Sporadic Creutzfeldt-Jakob disease: magnetic resonance imaging and 69. Atalay FÖ, Tolunay Ş, Özgün G, Bekar A, Zarifoğlu M. Creutzfeldt-
clinical findings. Neurology 2004;63:450-6. Jakob disease: report of four cases and review of the literature. Turk
67. Centers for Disease Control and Prevention. CDC’s Diagnostic Patoloji Derg 2015;31:148-52.
144 Neuroimmunology and Neuroinflammation ¦ Volume 4 ¦ July 21, 2017
